Market revenue in 2023 | USD 21,816.8 million |
Market revenue in 2030 | USD 36,871.7 million |
Growth rate | 7.8% (CAGR from 2023 to 2030) |
Largest segment | Personalized nutrition & wellness |
Fastest growing segment | PM Therapeutics |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PM Diagnostics, PM Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Illumina Inc, Asure Software Inc, Abbott Laboratories, Danaos Corp, Exact Sciences Corp, Danaher Corp, Amgen Inc, Qiagen NV, Exagen Inc Ordinary Shares, Quest Diagnostics Inc, Biogen Inc, Genelux Corp, International Business Machines Corp, Genentech, 23andMe Holding Co Class A |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to personalized medicine market will help companies and investors design strategic landscapes.
Personalized nutrition & wellness was the largest segment with a revenue share of 35.54% in 2023. Horizon Databook has segmented the Middle East & Africa personalized medicine market based on pm diagnostics, pm therapeutics, personalized medical care, personalized nutrition & wellness covering the revenue growth of each sub-segment from 2018 to 2030.
In the Middle East and Africa, the growth of the genomics field is slow, but it is gaining momentum with the emergence of various national genome projects in the UAE, Saudi Arabia, Kuwait, and Qatar. The Saudi Human Genome Program (SHGP), the UAE Human Genome Project, the Qatar Genome Programme (QGP), and the Kuwait Genome Project are among the few genomic projects.
In addition, continuous efforts are being undertaken by public agencies to boost the availability of genomic data of MEA population, which supports the development of predictive tests and targeted therapies. For instance, in February 2018, The Dubai Health Authority introduced its genome project or the Dubai 10X initiative.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa personalized medicine market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa personalized medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account